(Q58377805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

randomized controlled trial

18 January 2020

main subject

1 reference

based on heuristic

inferred from title

cryoglobulinemic vasculitis

1 reference

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Alen Zabotti

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Massimo Galli

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

S De Vita

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

L Quartuccio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Isola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

C Mazzaro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P Scaini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Lenzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Campanini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

C Naclerio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Tavoni

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Pietrogrande

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

C Ferri

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P Masolini

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Maset

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

D Roccatello

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A L Zignego

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P Pioltelli

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Gabrielli

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

D Filippini

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

O Perrella

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Migliaresi

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Bombardieri

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

G Monti

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

843-853

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability.

18 January 2020

cites work

1 reference

Hepatitis C virus in patients with cryoglobulinemia type II.

21 January 2018

1 reference

21 January 2018

1 reference

New roles for rheumatoid factor

21 January 2018

1 reference

Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?

21 January 2018

1 reference

HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations

21 January 2018

1 reference

PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis

21 January 2018

1 reference

Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study

21 January 2018

1 reference

Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication.

21 January 2018

1 reference

Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.

21 January 2018

1 reference

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

21 January 2018

1 reference

Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis

21 January 2018

1 reference

Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids

21 January 2018

1 reference

Efficacy of low-dose rituximab for mixed cryoglobulinemia

21 January 2018

1 reference

Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

21 January 2018

1 reference

Preliminary classification criteria for the cryoglobulinaemic vasculitis

21 January 2018

1 reference

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry

21 January 2018

1 reference

Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis

21 January 2018

1 reference

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA.

21 January 2018

1 reference

Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.

21 January 2018

1 reference

Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy.

21 January 2018

1 reference

Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases

21 January 2018

1 reference

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

21 January 2018

1 reference

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

21 January 2018

1 reference

Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia

21 January 2018

1 reference

Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.

21 January 2018

1 reference

Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

21 January 2018

1 reference

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.

21 January 2018

1 reference

Rituximab may form a complex with iGmÎº mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virusâ induced vasculitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.34331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147661%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference